The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
North America Cephalosporin Drugs Market (2019-2025)
US$ 1,500.00
The North America Cephalosporin Drugs Market would witness market growth of 4.69% CAGR during the forecast period (2019–2025). Market growth is driven by the implementation of combination drugs like various antibacterials ...
July 2019
98 pages
Breast Cancer Drug - Global Market Outlook (2017-2026)
US$ 4,150.00
According to Stratistics MRC, the Global Breast Cancer Drug Market is accounted for $14.75 billion in 2017 and is expected to reach $43.27 billion by ... companies in this region. Some of the key players profiled in the Breast cancer drug Market include Novartis AG, Celgene Corporation, Janssen Global Services LLC ...
July 2019
154 pages
Narcolepsy Drugs Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
... lucrative opportunities for market expansion. The global narcolepsy drugs market is segmented based on disease type, therapeutics type, and geography. Depending on disease type, the market is categorized into ...
July 2019
166 pages
Dupixent- Drug Insight, 2019
US$ 1,000.00
... the Dupixent SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Dupixent Access to Dupixent API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Dupixent patents ...
July 2019
35 pages
Imfinzi- Drug Insight, 2019
US$ 1,000.00
... the Imfinzi SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Imfinzi Access to Imfinzi API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Imfinzi patents ...
July 2019
35 pages
Ocrevus- Drug Insight, 2019
US$ 1,000.00
... the Ocrevus SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Ocrevus Access to Ocrevus API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Ocrevus patents ...
July 2019
35 pages
Parsabiv- Drug Insight, 2019
US$ 1,000.00
... the Parsabiv SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Parsabiv Access to Parsabiv API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Parsabiv patents ...
July 2019
35 pages
Radicava- Drug Insight, 2019
US$ 1,000.00
... the Radicava SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Radicava Access to Radicava API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Radicava patents ...
July 2019
35 pages
Rydapt- Drug Insight, 2019
US$ 1,000.00
... the Rydapt SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Rydapt Access to Rydapt API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Rydapt patents ...
July 2019
35 pages
Symproic- Drug Insight, 2019
US$ 1,000.00
... the Symproic SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Symproic Access to Symproic API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Symproic patents ...
July 2019
35 pages
Balversa- Drug Insight, 2019
US$ 1,000.00
... the Balversa SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Balversa Access to Balversa API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Balversa patents ...
July 2019
35 pages
Bevyxxa- Drug Insight, 2019
US$ 1,000.00
... the Bevyxxa SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Bevyxxa Access to Bevyxxa API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Bevyxxa patents ...
July 2019
35 pages
Biktarvy- Drug Insight, 2019
US$ 1,000.00
... the Biktarvy SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Biktarvy Access to Biktarvy API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Biktarvy patents ...
July 2019
35 pages
Erleada- Drug Insight, 2019
US$ 1,000.00
... the Erleada SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Erleada Access to Erleada API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Erleada patents ...
July 2019
35 pages
Fasenra- Drug Insight, 2019
US$ 1,000.00
... the Fasenra SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Fasenra Access to Fasenra API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Fasenra patents ...
July 2019
35 pages
Galafold- Drug Insight, 2019
US$ 1,000.00
... the Galafold SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Galafold Access to Galafold API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Galafold patents ...
July 2019
35 pages
Hemlibra- Drug Insight, 2019
US$ 1,000.00
... the Hemlibra SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Hemlibra Access to Hemlibra API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Hemlibra patents ...
July 2019
35 pages
Lutathera- Drug Insight, 2019
US$ 1,000.00
... the Lutathera SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Lutathera Access to Lutathera API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Lutathera patents ...
July 2019
35 pages
Mavyret- Drug Insight, 2019
US$ 1,000.00
... the Mavyret SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Mavyret Access to Mavyret API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Mavyret patents ...
July 2019
35 pages
Mayzent- Drug Insight, 2019
US$ 1,000.00
... the Mayzent SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Mayzent Access to Mayzent API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Mayzent patents ...
July 2019
35 pages
Nerlynx- Drug Insight, 2019
US$ 1,000.00
... the Nerlynx SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Nerlynx Access to Nerlynx API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Nerlynx patents ...
July 2019
35 pages
Symdeko- Drug Insight, 2019
US$ 1,000.00
... the Symdeko SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Symdeko Access to Symdeko API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Symdeko patents ...
July 2019
35 pages
Tremfya- Drug Insight, 2019
US$ 1,000.00
... the Tremfya SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Tremfya Access to Tremfya API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Tremfya patents ...
July 2019
35 pages
Verzenio- Drug Insight, 2019
US$ 1,000.00
... the Verzenio SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Verzenio Access to Verzenio API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Verzenio patents ...
July 2019
35 pages
Vosevi- Drug Insight, 2019
US$ 1,000.00
... the Vosevi SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Vosevi Access to Vosevi API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Vosevi patents ...
July 2019
35 pages
Xospata- Drug Insight, 2019
US$ 1,000.00
... the Xospata SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Xospata Access to Xospata API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Xospata patents ...
July 2019
35 pages
Global Ascorbyl Palmitate (Vitamin C Palmitate) Market Outlook 2019-2024
US$ 3,000.00
... challenges for global ascorbyl palmitate market. To examine competitive developments such as expansions, mergers & acquisitions, etc., in global ascorbyl palmitate market. To conduct pricing analysis for global ascorbyl palmitate market. To identify ...
June 2019
93 pages
Global Folic Acid (Vitamin B9) Market Outlook 2019-2024
US$ 3,000.00
... challenges for global folic acid market. To examine competitive developments such as expansions, mergers & acquisitions, etc., in global folic acid market. To conduct pricing analysis for global folic acid market. To identify ...
June 2019
115 pages
Global Pyridoxine (Vitamin B6) Market Outlook 2019-2024
US$ 3,000.00
... basis of product, the global pyridoxine market is segmented into: Food Grade Vitamin B6 Feed Grade Vitamin B6 Pharmaceutical Grade Vitamin B6 Based on application, the pyridoxine market is segmented into: Agriculture Animal ...
June 2019
139 pages
Global Thiamine (Vitamin B1) Market Outlook 2019-2024
US$ 3,000.00
... and forecast the market size of global thiamine market. To classify and forecast global thiamine market based on region, and application. To identify drivers and challenges for global thiamine market. To examine competitive ...
June 2019
129 pages
Global Vitamin H (Biotin, Vitamin B7) Market Outlook 2019-2024
US$ 3,000.00
... , the global vitamin h market is segmented into: Food Grade Vitamin H Feed Grade Vitamin H Pharmaceutical Grade Vitamin H Based on application, the vitamin h market ... analyze and forecast the market size of global vitamin h market. To classify and forecast global vitamin h market based on region, product, and ...
June 2019
122 pages
Global Immunotherapy Drugs Market Size Study, by Type of Drugs (Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins, Others) by Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others) by End-Use (Hospitals, Clinics, Others) by Regional Forecasts 2018-2025
US$ 3,750.00
... significant opportunities in the APAC immunotherapy drugs market. On the basis of end-use, the global immunotherapy drugs market is segmented into hospitals, ... Audience of the Global Immunotherapy Drugs Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises ...
May 2019
200 pages
Global Contraceptive Pills Market By Pill Type (Progestin Pills & Combination Pills), By Category (Generic & Branded), By Sales Channel (Offline & Online), By Region (North America, Europe, APAC, South America & MEA), Competition, Forecast & Opportunities, 2024
US$ 4,500.00
... etc. in global contraceptive pills market To conduct pricing analysis for global contraceptive pills market To identify and analyze the profile of leading players involved in global contraceptive pills market Some of the leading players in global contraceptive pills market are ...
May 2019
112 pages
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
US$ 3,390.00
... drugs held the largest share of the vitamin D therapy market in 2018.” On the basis of purchasing pattern, the vitamin D therapy market is segmented into OTC and prescription drugs ...
April 2019
113 pages
Immunotherapy Drugs Market
US$ 3,250.00
... Overview of the Global Immunotherapy Drugs Market Infoholic’s market research report predicts that the “Global Immunotherapy Drugs Market” will grow at ... favorable reimbursement policies. Immunotherapy Drugs Market Research Competitive Analysis – The global immunotherapy drugs market has massive growth ...
April 2019
104 pages
Heart failure drugs market
US$ 3,250.00
... growth of heart failure drugs industry. Factors influencing the growth of the heart failure drugs market. In-depth competitive analysis of dominant and pureplay vendors. Prediction analysis of the heart failure drugs market in both ...
April 2019
88 pages
Global Probiotic Supplements Market (2018 – 2027)
US$ 2,950.00
... . Regional insights: The North America probiotic supplements market is projected to expand at a CAGR of 10.68% during the 2018-2027 period, leading to a global revenue of USD 1483.1 Mn by 2027. Increasing ...
April 2019
90 pages
Global Antiretroviral Drugs Market: Analysis By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors), By Region, By Country, Drug Forecast (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, South Africa)
US$ 2,400.00
... analysis. SCOPE OF THE REPORT Global Antiretroviral Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023) Antiretroviral Drugs Market– Size, Growth, Forecast Analysis By Drug Type - Multi-Class Drugs Combination Drugs ...
March 2019
230 pages
Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)
US$ 2,200.00
... According to Azoth Analytics research report “Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating ... medical infrastructural developments. The report titled “Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating ...
March 2019
200 pages
Oral Drug Delivery Market - Forecasts from 2019 to 2024
US$ 3,800.00
... Oral drug delivery market is projected to grow at a CAGR of 6.99% to reach US$150.063 billion by 2024, from US$100.050 billion in 2018. Oral drug delivery is referred to the transfer of drug ... and SPI Pharma among others. Segmentation The oral drug delivery market has been analyzed through following segments: By ...
March 2019
112 pages
North America Drug Delivery Market - Forecasts from 2019 to 2024
US$ 3,200.00
... others. Segmentation The North America drug delivery market has been analyzed through following segments: By Type Inhalation Drug Delivery Injectable Drug Delivery Nasal Drug Delivery Oral Drug Delivery Transdermal Drug Delivery By Application Disease Treatment ...
March 2019
106 pages
Nasal Drug Delivery Market - Forecasts from 2019 to 2024
US$ 3,800.00
... Company plc. Segmentation The nasal drug delivery market has been analyzed through following segments: By Dosage Form Nasal Spray Nasal Drops Nasal Ointment Others By Application Disease ...
March 2019
110 pages
Global Vitamin Consumption Market Size study, by Type (Vitamin A, Vitamin B3, Vitamin B5, Vitamin D3, Vitamin E, Vitamin C, Others), by Application (Feed Additives, Pharmaceuticals and Cosmetics, Food and Beverages) and Regional Forecasts 2018-2025
US$ 3,750.00
... – 2018 to 2025 Target Audience of the Global Vitamin Consumption Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
March 2019
200 pages
Inhalation Drug Delivery Market - Forecasts from 2019 to 2024
US$ 3,800.00
... inhalation drug delivery market is projected to grow at a CAGR of 3.58% to reach US$ 43.011 billion by 2024, from US$ 34.828 billion in 2018. Inhalation drug delivery is referred to the transfer of drug ... AG among others. Segmentation The inhalation drug delivery market has been analyzed through following ...
March 2019
108 pages
Injectable Drug Delivery Market - Forecasts from 2019 to 2024
US$ 3,800.00
... clients in gaining faster and efficient understanding of the injectable drug delivery market. Major industry players profiled as part of the ... Owen Mumford Ltd, SHL Medical AG, Enable Injections, and Ypsomed AG. Segmentation The injectable drug delivery market has been analyzed through following segments: By ...
March 2019
104 pages
